Skip to main content
Premium Trial:

Request an Annual Quote

Joint Genome Institute Buys 60 More Sequencing Machines from Amersham


WALNUT CREEK,Calif.--The US Department of Energy's Joint Genome Institute has purchased an additional 60 MegaBace 1000 high-throughput DNA sequencers from Amersham Pharmacia Biotech, Nycomed Amersham's life science business. This acquisition brings the number of MegaBace sequencers in operation at the institute to 86. Trevor Hawkins, the institute's director of sequencing, said, "Since our initial order was installed in June, we have been extremely impressed with the results and performance of MegaBace."

Filed under

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.